CD48⁺ tumour-associated macrophages: novel immunotherapeutic targets in hepatocellular carcinoma

Gut. 2026 Apr 21:gutjnl-2026-338840. doi: 10.1136/gutjnl-2026-338840. Online ahead of print.

Authors

Xiaolu Zhang¹, Natascha Roehlen²

Affiliations

¹ Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China xiaolu.zhang@sdu.edu.cn.
² University Hospital Freiburg Department of Internal Medicine II Gastroenterology Hepatology Endocrinology and Infectiology, Freiburg, Germany.

PMID: 42014189
DOI: 10.1136/gutjnl-2026-338840

No abstract available

Keywords: HEPATOCELLULAR CARCINOMA; IMMUNOTHERAPY; LIVER IMMUNOLOGY.